ASHFORD CAPITAL MANAGEMENT INC
Q2 2026 Form 13-F

WILMINGTON, DELAWARE
CIK 0000897070 · CRD 110696 · SEC-registered investment adviser
$932.6M Reported Value Total

ASHFORD CAPITAL MANAGEMENT INC reports 95 total accounts under management (AUM). There are 95 discretionary accounts valued at $965,833,061, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
4 funds · $219.2M gross asset value
Hedge Fund: $219.2M
Source: Form ADV filed 2026-07-28
Reported value
$932.6M
Quarter over quarter
+22.0%
Holdings
107
Top-10 concentration
36.5%

Key People

Form ADV owners & control persons
Theodore H. Ashford III
CHIEF EXECUTIVE OFFICER, DIRECTOR, CHIEF INVESTMENT OFFICER (CLASS A&B SHARES)
Theodore H Ashford
CHAIRMAN, DIRECTOR (CLASS A SHARES)
Louise Victoria Horan
VICE PRESIDENT, OPERATIONS (CLASS B SHARES)

Filing Navigation

13F Metrics

Loading 13F Metrics

Q2 2026 13F record

Q2 2026 13F filing summary

Q2 2026 Form 13F portfolio summary
Period of report June 30, 2026
Filed August 21, 2026
Form 13F-HR
Reported value $932.6M
Positions 107
Change in reported value +15.3%
New positions 17
Exited positions 9
Position turnover 22.4%
Top-10 concentration 36.5%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 21, 2026
107 $932.6M
Q1 2026 13F
Filed May 15, 2026
99 $809.2M
Q4 2025 13F
Filed Feb 17, 2026
109 $897.7M
Q3 2025 13F
Filed Nov 14, 2025
110 $897.8M
Q2 2025 13F
Filed Aug 18, 2025
102 $851.1M
Q1 2025 13F
Filed May 15, 2025
99 $775.5M
Q4 2024 13F
Filed Feb 18, 2025
101 $847.6M
Q3 2024 13F
Filed Nov 18, 2024
102 $801.3M
Q2 2024 13F
Filed Aug 15, 2024
97 $740.6M
Q1 2024 13F
Filed May 15, 2024
91 $739.3M
Q4 2023 13F
Filed Feb 15, 2024
93 $746.4M
Q3 2023 13F
Filed Nov 15, 2023
91 $679.3M
Q2 2023 13F
Filed Aug 14, 2023
90 $715.5M
Q1 2023 13F
Filed May 15, 2023
90 $668.0M
Q4 2022 13F
Filed Feb 15, 2023
90 $644.9M
Q3 2022 13F
Filed Nov 16, 2022
92 $655.6M
Q2 2022 13F
Filed Aug 15, 2022
92 $703.7M
Q1 2022 13F
Filed May 16, 2022
101 $928.5M
Q4 2021 13F
Filed Feb 15, 2022
107 $1.0B
Q3 2021 13F
Filed Nov 15, 2021
113 $1.1B

33 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2026

Largest Q2 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 LGND LIGAND PHARMACEUTICALS - CL B $53.8M 5.77%
2 GSAT GLOBALSTAR INC. $41.4M 4.44%
3 RDVT RED VIOLET INC $36.7M 3.93%
4 VTI VANGUARD TOTAL STOCK MARKET ETF $35.9M 3.85%
5 SNEX STONEX GROUP, INC. $32.7M 3.51%
6 SUPN SUPERNUS PHARMACEUTICALS INC. $28.5M 3.06%
7 VICR VICOR CORP $28.5M 3.05%
8 AYI ACUITY, INC. $27.9M 2.99%
9 UFPT UFP TECHNOLOGIES, INC. $27.8M 2.99%
10 YOU CLEAR SECURE, INC. -CLASS A $26.7M 2.86%
11 CLBT CELLEBRITE DI LTD/ISRAEL $26.0M 2.78%
12 FROG JFROG LTD $24.7M 2.65%
13 EQIX EQUINIX INC $23.2M 2.49%
14 HQY HEALTHEQUITY, INC. $22.9M 2.45%
15 SKWD SKYWARD SPECIALTY INSURANCE GROUP $21.5M 2.3%
16 IDCC INTERDIGITAL INC. $21.2M 2.28%
17 INCY INCYTE CORP $20.7M 2.21%
18 LB LANDBRIDGE COMPANY, LLC $18.6M 2.0%
19 VNOM VIPER ENERGY, INC. $18.1M 1.94%
20 ABL ABACUS GLOBAL MANAGEMENT, INC $17.9M 1.92%

Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Similar Managers

Finding Similar Managers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings